Last Updated on October 15, 2024 by The Health Master
Lupin today announced that it has received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Sildenafil for oral suspension, 10 mg/mL.
This approval is to market a generic equivalent of Revatio for oral suspension, 10 mg/mL, of Viatris Specialty LLC.
The product will be manufactured at Lupin’s facility in Goa, according to a company statement.
Sildenafil for oral suspension, 10 mg/mL (RLD Revatio) had estimated annual sales of $66 million in the US (IQVIA MAT December 2021), the statement added.
USFDA gives approval to Glenmark Pharma for Lacosamide Tablets
USFDA approves drug for treatment of Seizures associated with rare disease
USFDA approves new Bristol Myers cancer Immunotherapy
USFDA approves first generic of Symbicort to treat Asthma and COPD
USFDA gives nod to Lupin for Vigabatrin for Oral Solution
USFDA gives tentative nod to Alembic for Macitentan Tablets 10 mg
NPPA’s expert panel recommends retail price for FDCs of anti-diabetic linagliptin
DCGI gives nod to Phase-3 Clinical Trial of Covovax Vaccine
Drug recall: This drug recalled due to detection of NDMA
Drug recall: Some lots of Blood Pressure Drug due to this…
CDSCO approves Sputnik Light vaccine for manufacture for sale in India
USFDA gives approval to Glenmark Pharma for Lacosamide Tablets
Govt Job: For B.Pharm in FDA under Public Service Commission
Pharma firm Director and 4 others held for illegal export of Tramadol
CDSCO penal asked for more data on Tildrakizumab
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
